SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who started this subject11/15/2000 4:56:33 AM
From: nigel bates  Read Replies (2) of 1022
 
I missed this (nothing new on their website for a few months..)
Message 14810276
"...Biovation Limited is a UK-based biopharmaceutical company specialising in antibody and protein engineering
technology. It recently joined the Merck Group of companies. Biovation's proprietary DeImmunization technology is
designed to prevent adverse immunological reactions in patients, which can limit the therapeutic potential of monoclonal
antibodies and other proteins. Biovation has, to date, applied this technology for partners in the USA, Europe, Australia, Taiwan and Japan leading to several new product candidates for a variety of diseases...."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext